Mindray Medical International (NYSE: MR) and IRIDEX (NASDAQ:IRIX) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.
This table compares Mindray Medical International and IRIDEX’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Mindray Medical International||15.93%||12.70%||8.37%|
This is a breakdown of recent ratings for Mindray Medical International and IRIDEX, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Mindray Medical International||0||0||0||0||N/A|
IRIDEX has a consensus price target of $13.00, suggesting a potential upside of 49.60%. Given IRIDEX’s higher probable upside, analysts clearly believe IRIDEX is more favorable than Mindray Medical International.
Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. IRIDEX does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.
Institutional & Insider Ownership
49.3% of IRIDEX shares are owned by institutional investors. 5.0% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Mindray Medical International and IRIDEX’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Mindray Medical International||N/A||N/A||N/A||$1.49||18.75|
|IRIDEX||$46.16 million||2.18||-$11.71 million||($1.71)||-5.08|
Mindray Medical International has higher earnings, but lower revenue than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Mindray Medical International, indicating that it is currently the more affordable of the two stocks.
IRIDEX beats Mindray Medical International on 6 of the 11 factors compared between the two stocks.
About Mindray Medical International
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
Receive News & Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related companies with MarketBeat.com's FREE daily email newsletter.